Cargando…

Controversies about immunoglobulin replacement therapy in HSCT recipients with hypogammaglobulinemia

The efficacy of immunoglobulin replacement therapy (IgRT) has been demonstrated for primary immune deficiency diseases and hematological malignancies such as chronic lymphocytic leukemia (CLL) or multiple myeloma with hypogammaglobulinemia. Clinical development of anti-B cell therapies including a m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ohmoto, Akihiro, Fuji, Shigeo, Shultes, Kendall C., Savani, Bipin N., Einsele, Hermann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017083/ https://www.ncbi.nlm.nih.gov/pubmed/35440805 http://dx.doi.org/10.1038/s41409-022-01680-z

Ejemplares similares

Immunoglobulin Replacement Therapy in Secondary Hypogammaglobulinemia
por: Compagno, Nicolò, et al.
Publicado: (2014)

Hypogammaglobulinemia in pediatric kidney transplant recipients
por: Dimitriades, Victoria, et al.
Publicado: (2022)

Persistent Hypogammaglobulinemia after Receiving Rituximab Post-HSCT Is Not Caused by an Intrinsic B Cell Defect
por: Ott de Bruin, Lisa M., et al.
Publicado: (2023)

Case Report: Persistent Hypogammaglobulinemia More Than 10 Years After Rituximab Given Post-HSCT
por: Luterbacher, Fanny, et al.
Publicado: (2021)

Lifelong immunoglobulin replacement is not always necessary: A case description of a patient with recurrent infections and hypogammaglobulinemia
por: Napiorkowska-Baran, Katarzyna, et al.
Publicado: (2019)

Antiemetic Strategies in Patients Who Undergo Hematopoietic Stem Cell Transplantation
por: Yuda, Sayako, et al.
Publicado: (2022)

Does Intravenous Immunoglobulin Therapy Prolong Immunodeficiency in Transient Hypogammaglobulinemia of Infancy?
por: Memmedova, Lale, et al.
Publicado: (2013)

4396 Immunoglobulin administration and hypogammaglobulinemia during pediatric acute leukemia therapy
por: Edington, Holly, et al.
Publicado: (2020)

Should treatment of hypogammaglobulinemia with immunoglobulin replacement therapy (IgRT) become standard of care in patients with chronic lymphocytic leukemia?
por: Noto, Alessandro, et al.
Publicado: (2023)

Association of Immunoglobulin Levels, Infectious Risk, and Mortality With Rituximab and Hypogammaglobulinemia
por: Barmettler, Sara, et al.
Publicado: (2018)

Alloreactivity of Virus-Specific T Cells: Possible Implication of Graft-Versus-Host Disease and Graft-Versus-Leukemia Effects
por: Fuji, Shigeo, et al.
Publicado: (2013)

Monitoring of Pathogen-Specific T-Cell Immune Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation
por: Fuji, Shigeo, et al.
Publicado: (2013)

Possible Implication of Bacterial Infection in Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
por: Fuji, Shigeo, et al.
Publicado: (2014)

Intravenous Immunoglobulin for Hypogammaglobulinemia after Lung Transplantation: A Randomized Crossover Trial
por: Lederer, David J., et al.
Publicado: (2014)

What is known about deferasirox chelation therapy in pediatric HSCT recipients: two case reports of metabolic acidosis
por: Fucile, Carmen, et al.
Publicado: (2018)

Biological and Genetic Aspects of Donor-Recipient Matching in HSCT
por: Lange, Andrzej, et al.
Publicado: (2012)

Clinical Characteristics and Outcomes of COVID-19 in HSCT Recipients
por: Machado, Clarisse MARTINS, et al.
Publicado: (2020)

Fusarium infection manifesting as toe cellulitis in HSCT recipient
por: Malkiel, Sarah, et al.
Publicado: (2022)

Immunoglobulin repletion during blinatumomab therapy does not reduce the rate of secondary hypogammaglobulinemia and associated infectious risk
por: Wo, Stephanie, et al.
Publicado: (2022)

Hypogammaglobulinemia with Facial Edema
por: Knight, Adina Kay, et al.
Publicado: (2006)

Rituximab Use and Hypogammaglobulinemia
por: Alhassan, Eaman, et al.
Publicado: (2020)

P1516: THE CLINICAL IMPACT OF IMMUNOGLOBULIN REPLACEMENT THERAPY ON SEVERE BACTERIAL INFECTION IN PATIENTS WITH HYPOGAMMAGLOBULINEMIA SECONDARY TO HEMATOLOGIC MALIGNANCIES: A JAPANESE CLAIMS DATABASE STUDY
por: Mihara, Keichiro, et al.
Publicado: (2023)

Hypogammaglobulinemia due to CAR T-cell therapy
por: Doan, Andrew, et al.
Publicado: (2017)

Continuous non-invasive monitoring of the skin temperature of HSCT recipients
por: van Vliet, Maarten, et al.
Publicado: (2009)

Low immunoglobulin levels increase the risk of severe hypogammaglobulinemia in granulomatosis with polyangiitis patients receiving rituximab
por: Besada, Emilio
Publicado: (2016)

Transient hypogammaglobulinemia and severe atopic dermatitis: Open-label treatment with immunoglobulin in a case series
por: Breslin, Moira E., et al.
Publicado: (2016)

Tonsillar granuloma associated with hypogammaglobulinemia
por: Laajala, Aleksi, et al.
Publicado: (2020)

Lymphocytosis, Lymphocytopenia, Hypergammaglobulinemia, and Hypogammaglobulinemia
por: Mims, Martha P.
Publicado: (2018)

COVID-19, plasma, and hypogammaglobulinemia
por: Murphy, Michael F., et al.
Publicado: (2020)

Prevention and management of human cytomegalovirus in pediatric HSCT recipients: A review
por: Hiskey, Lisa, et al.
Publicado: (2022)

Enhanced serum immunoglobulin G clearance in myotonic dystrophy-associated hypogammaglobulinemia: a case series and review of the literature
por: Sasson, Sarah C., et al.
Publicado: (2019)

The Controversial History of Hormone Replacement Therapy
por: Cagnacci, Angelo, et al.
Publicado: (2019)

The clinical course of COVID-19 in hematopoietic stem cell transplantation (HSCT) recipients
por: KARATAŞ, Ayşe, et al.
Publicado: (2021)

Hypogammaglobulinemia: a diagnosis that must not be overlooked
por: Pimenta, F.M.C.A., et al.
Publicado: (2019)

Rituximab Associated Hypogammaglobulinemia in Autoimmune Disease
por: Tieu, Joanna, et al.
Publicado: (2021)

Subcutaneous immunoglobulin replacement therapy in a heart transplant recipient with severe recurrent infections
por: Carbone, Javier, et al.
Publicado: (2015)

452 Pseudo-Outbreak of Fulminant Toxoplasmosis in Hematopoietic Stem Cell Transplant [HSCT] Recipients
por: Isa, Flonza, et al.
Publicado: (2014)

606 Case Report: Hypogammaglobulinemia Induced by Oxcarbazepine
por: Marinovic, Maria Angelica, et al.
Publicado: (2012)

B cell aplasia and hypogammaglobulinemia associated with levetiracetam
por: Ozdemir, Hulya, et al.
Publicado: (2018)

Mild Hypogammaglobulinemia Can Be a Serious Condition
por: Janssen, Lisanne M. A., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_i72e7ubs6dod5iu887qhhck649